Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALKS

Alkermes plc

May 29 • 04:00PM ET

42.19

+2.25 5.63 %

Healthcare • Drug Manufacturers - Specialty & Generic • Ireland • Mid • NASD

Peers: NBIX ACAD INCY BIIB PFE VRTX BMY ABBV LLY MRK

| Held by: IJR VTI IWM XBI AVUV VB FBT VBK VXF SPSM

Scroll to Statements

Index	RUT	P/E	46.90	EPS (ttm)	0.90	Insider Own	2.23%	Shs Outstand	166.46M	Perf Week	14.18%
Market Cap	7.03B	Forward P/E	73.70	EPS next Y	0.57	Insider Trans	-3.91%	Shs Float	162.96M	Perf Month	25.16%
Enterprise Value	8.10B	PEG	-	EPS next Q	-0.01	Inst Own	107.46%	Short Float	11.22%	Perf Quarter	40.17%
Income	152.72M	P/S	4.50	EPS this Y	-125.79%	Inst Trans	-1.51%	Short Ratio	7.82	Perf Half Y	45.53%
Sales	1.56B	P/B	4.01	EPS next Y	255.20%	ROA	4.82%	Short Interest	18.28M	Perf YTD	50.79%
Book/sh	10.52	P/C	13.74	EPS next 5Y	-1.72%	ROE	9.36%	52W High	40.79 3.43%	Perf Year	39.47%
Cash/sh	3.07	P/FCF	31.70	EPS past 3/5Y	- -	ROIC	4.63%	52W Low	25.17 67.65%	Perf 3Y	54.79%
Dividend Est.	-	EV/EBITDA	35.06	Sales past 3/5Y	9.90% 7.28%	Gross Margin	85.51%	Volatility	4.58% 3.89%	Perf 5Y	100.20%
Dividend TTM	-	EV/Sales	5.19	EPS Y/Y TTM	-56.86%	Oper. Margin	12.28%	ATR (14)	1.43	Perf 10Y	-1.62%
Dividend Ex-Date	-	Quick Ratio	1.70	Sales Y/Y TTM	3.21%	Profit Margin	9.78%	RSI (14)	77.53	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	2.27	EPS Q/Q	-400.53%	SMA20	13.95%	Beta	0.36	Target Price	45.44
Payout	0.00%	Debt/Eq	0.90	Sales Q/Q	28.19%	SMA50	22.61%	Rel Volume	1.82	Prev Close	39.94
Employees	2050	LT Debt/Eq	0.88	Earnings	May 05 BMO	SMA200	35.43%	Avg Volume	2.34M	Price	42.19
IPO	Jul 16, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	26.74% 8.22%	Trades		Volume	4,243,073	Change	5.63%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)